VAL-ZOLEDRONIC ACID DIN 02426412
Status: Approved
Holder: BAUSCH HEALTH, CANADA INC.
Health Canada record
| Active ingredient(s) | ZOLEDRONIC ACID (ZOLEDRONIC ACID HEMIPENTAHYDRATE) 4 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BA08 ZOLEDRONIC ACID |
| Original market date | |
| Current status date | 16-Sep-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26669 | 2021-09-16 | Abbreviated New Drug Submission (ANDS) | Administrative: Change in Product Ownership |
| 16338 | 2014-11-24 | Abbreviated New Drug Submission (ANDS) |